News | Advanced Visualization | October 07, 2016

UCHealth Expands ClearRead Bone Suppression and ClearRead Confirm System-Wide

All five hospitals in Colorado system now have access to tools to enhance detection of lung disease

Riverain Technologies, ClearRead Bone Suppression, ClearRead Confirm, UCHealth, University of Colorado, chest X-ray, lung cancer detection

October 7, 2016 — UCHealth (Colorado) has expanded their use of Riverain’s ClearRead Bone Suppression and ClearRead Confirm software to all five of their flagship hospitals. The expansion will ensure patients across the entire network benefit from the same tools designed to aid in more effective detection of lung disease, including lung cancer. Utilization of the ClearRead tools across UCHealth ensures patients and clinicians benefit from the technology independent of the imaging location within the network.

“The ClearRead technology enables us to detect lung disease and critical care devices such as tubes and lines more quickly and efficiently,” said Peter Sachs, M.D., associate professor and chief of cardiothoracic imaging at the University of Colorado Hospital. “This results in more accurate and earlier diagnoses, ensuring the best possible outcomes for our patients.”

UCHealth is a nationally recognized system of five hospitals and more than 100 clinics including University of Colorado Hospital, Poudre Valley Hospital, Medical Center of the Rockies, Memorial Hospital Central and Memorial Hospital North.

ClearRead Bone Suppression forms a soft tissue image by subtracting the ribs and clavicles from the standard chest X-ray, allowing radiologists to more effectively detect lung disease. Powered by cutting-edge machine learning, it is the only software product to perform robust, pixel level bone suppression throughout the entire body, according to Riverain.

The ClearRead Confirm optimizes the visual quality of chest X-rays, including improving the conspicuity of lines and tubes on portable images, allowing radiologists to read up to 19 percent faster.

For more information: www.riveraintech.com

Related Content

Ghost imaging approach could enable detailed movies of the heart with low-dose X-rays

Researchers developed a high-resolution X-ray imaging technique based on ghost imaging that can capture the motion of rapidly moving objects. They used it to create a movie of a blade rotating at 100,000 frames per second. Image courtesy of Sharon Shwartz, Bar-Ilan University

News | X-Ray | August 06, 2020
August 6, 2020 — Researche...
Imaging volumes in hospitals and practices previously slowed by the coronavirus pandemic continue to hold steady, according to new QuickPoLL survey results that gauge how radiologists feel about current business and the impact of COVID-19.
Feature | Coronavirus (COVID-19) | August 03, 2020 | By Melinda Taschetta-Millane
Imaging volumes in hospitals and practices previously slowed by the coronavirus pandemic continue to hold steady, acc
Franco Fontana, CEO of the Esaote Group, and Xie Yufeng, Chairman of WDM.

Franco Fontana, CEO of the Esaote Group, and Xie Yufeng, Chairman of WDM.

News | Digital Radiography (DR) | July 31, 2020
July 31, 2020 — In the thick of the COVID-19 eme
Zebra Medical Vision announced its sixth FDA 510(k) clearance for its mammography solution, HealthMammo, which has already received a CE mark. Zebra Medical’s algorithm empowers breast radiologists by prioritizing and identifying suspicious mammograms, providing a safety net for radiologists. The suspicious mammograms are identified faster and read earlier than the current “first-in first-out” standard of care. 
News | Breast Imaging | July 27, 2020
July 26, 2020 —  Zebra Medical Vision announced its sixth FDA 510
Medical professionals around the world have been feeding lung X-rays into a database since the beginning of the pandemic

Pre-processing results. Image courtesy of Applied Sciences.

News | Coronavirus (COVID-19) | July 22, 2020
July 22, 2020 — Researchers from the Departme
News | Coronavirus (COVID-19) | July 20, 2020
July 20, 2020 — Racial/ethnic minority patients admitted to the hospital with...
This data represents wave 3 of a QuickPoLL survey conducted in partnership with an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business

Getty Images

Feature | Coronavirus (COVID-19) | July 15, 2020 | By Melinda Taschetta-Millane
This data represents wave 2 of a QuickPoLL survey conducted in partnership with an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business

Getty Images

Feature | Coronavirus (COVID-19) | July 01, 2020 | By Melinda Taschetta-Millane
Imaging Artificial Intelligence (AI) provider Qure.ai announced its first US FDA 510(k) clearance for its head CT scan product qER. The US Food and Drug Administration's decision covers four critical abnormalities identified by Qure.ai's emergency room product.
News | Artificial Intelligence | June 30, 2020
June 30, 2020 — Imaging Artificial Intelligence (AI) provider Qure.ai announced its first US FDA 510(k) clearance for
In new QuickPoLL survey on imaging during the pandemic, responses were tallied from around 170 radiology administrators and business managers, who are part of an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business. TMTG is a research firm specializing in the medical device, healthcare and pharmaceutical industries.
Feature | Coronavirus (COVID-19) | June 30, 2020 | By Melinda Taschetta-Millane